Entity

Time filter

Source Type

Washington, DC, United States

Greenwood J.C.,Biotechnology Industry Organization BIO
European Biotechnology Science and Industry News | Year: 2011

Until a decade ago, the United States was the undisputed leader in bioscience industry development. Global competition within the industry has dramatically increased - fueled in large part by low-cost labor, the speed of information dissemination, and available risk capital, in the United States, local and national government leaders continue to understand this new dynamic of increased competition for developing the biosciences and are actively working to expand and promote industry growth.


Erickson B.,Biotechnology Industry Organization BIO | Singh R.,Biotechnology Industry Organization BIO | Winters P.,Biotechnology Industry Organization BIO
Science | Year: 2011

In our view, synthetic biology is an extension of the continuum of genetic science that has been used safely for more than 40 years by the biotechnology industry in the development of commercial products. Examples of synthetic biology use by biotechnology companies illustrate the potential to substantially reduce research and development time and to increase speed to market. Improvements in the speed and cost of DNA synthesis are enabling scientists to designmodified bacterial chromosomes that can be used in the production of renewable chemicals, biofuels, bioproducts, renewable specialty chemicals, pharmaceutical intermediates, fine chemicals, food ingredients, and health care products. Regulatory options should support innovation and commercial development of new products while protecting the public from potential harms.

Discover hidden collaborations